Teradyne, Inc (TER) stock
Close on Oct 30, 2026Market cap $42.90BP/E 31.5Yield 0.17%
Earnings
Teradyne's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Teradyne's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 2, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 28, 2026 | Oct 28, 2026before the open | $1.31B | +69.8% | $2.17 | $2.29 | Release |
| Q2 FY2026ended Jun 28, 2026 | Jul 29, 2026before the open | $1.33B | +103.8% | $2.38 | $2.47 | Release |
| Q1 FY2026ended Mar 29, 2026 | Apr 29, 2026before the open | $1.28B | +86.9% | $2.53 | $2.56 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 3, 2026before the open | $1.08B | +43.8% | $1.63 | $1.80 | Release |
| Q3 FY2025ended Sep 28, 2025 | Oct 29, 2025before the open | $769.00M | +4.3% | $0.75 | $0.85 | Release |
| Q2 FY2025ended Jun 29, 2025 | Jul 30, 2025before the open | $652.00M | -10.7% | $0.49 | $0.57 | Release |
| Q1 FY2025ended Mar 30, 2025 | Apr 29, 2025before the open | $686.00M | +14.3% | $0.61 | $0.75 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 30, 2025before the open | $753.00M | +12.2% | $0.90 | $0.95 | Release |
| Q3 FY2024ended Sep 29, 2024 | Oct 24, 2024before the open | $737.00M | +4.7% | $0.89 | $0.90 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 25, 2024before the open | $730.00M | +6.7% | $1.14 | $0.86 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 25, 2024before the open | $600.00M | -2.9% | $0.40 | $0.51 | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 31, 2024before the open | $671.00M | – | $0.72 | $0.79 | Release |
| Q3 FY2023ended Oct 1, 2023 | Oct 26, 2023before the open | $704.00M | -14.9% | $0.78 | $0.80 | Release |
| Q2 FY2023ended Jul 2, 2023 | Jul 27, 2023before the open | $684.00M | – | $0.73 | $0.79 | Release |
| Q1 FY2023ended Apr 2, 2023 | Apr 27, 2023before the open | $618.00M | -18.1% | $0.50 | $0.55 | Release |
| Q4 FY2022ended Dec 31, 2022 | Jan 26, 2023before the open | – | – | – | – | Release |
| Q3 FY2022ended Oct 2, 2022 | Oct 26, 2022before the open | $827.00M | -13.0% | $1.10 | $1.15 | Release |
| Q2 FY2022ended Jul 3, 2022 | Jul 27, 2022before the open | – | – | – | – | Release |
| Q1 FY2022ended Apr 3, 2022 | Apr 27, 2022before the open | $755.00M | – | $0.92 | $0.98 | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 27, 2022before the open | $885.00M | – | $1.29 | $1.37 | Release |
| Q3 FY2021ended Oct 3, 2021 | Oct 27, 2021before the open | $951.00M | – | $1.41 | $1.59 | Release |
| Q2 FY2021ended Jul 4, 2021 | Jul 28, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Apr 4, 2021 | Apr 28, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 28, 2021before the open | – | – | – | – | Release |
| Q3 FY2020ended Sep 27, 2020 | Oct 21, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Teradyne's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenue | Q4 FY2026 | $1.25B – $1.35B | – | New | Oct 28, 2026 |
| GAAP net income attributable to Teradyne per diluted shareGAAP | Q4 FY2026 | $1.88 – $2.18 | – | New | Oct 28, 2026 |
| non-GAAP net income attributable to Teradyne per diluted sharenon-GAAP | Q4 FY2026 | $1.95 – $2.25 | – | New | Oct 28, 2026 |
Guidance vs results
The last range Teradyne gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | EPS (GAAP) | $1.79 – $2.09 | $2.17 | Above range |
| Q3 FY2026 | non-GAAP net income attributable to Teradyne per diluted share | $1.85 – $2.15 | $2.29 | Above range |
| Q3 FY2026 | Revenue | $1.20B – $1.30B | $1.31B | Above range |
| Q2 FY2026 | EPS (GAAP) | $1.83 – $2.12 | $2.38 | Above range |
| Q2 FY2026 | non-GAAP net income per diluted share | $1.86 – $2.15 | $2.47 | Above range |
| Q2 FY2026 | Revenue | $1.15B – $1.25B | $1.33B | Above range |
| Q1 FY2026 | EPS (GAAP) | $1.82 – $2.19 | $2.53 | Above range |
| Q1 FY2026 | non-GAAP net income per diluted share | $1.89 – $2.25 | $2.56 | Above range |
| Q1 FY2026 | Revenue | $1.15B – $1.25B | $1.28B | Above range |
| Q4 FY2025 | EPS (GAAP) | $1.12 – $1.39 | $1.63 | Above range |
| Q4 FY2025 | non-GAAP net income per diluted share | $1.20 – $1.46 | $1.80 | Above range |
| Q4 FY2025 | Revenue | $920.00M – $1.00B | $1.08B | Above range |
| Q4 FY2025 | Revenue growth | +25% | +43.82% | Above range |
| Q3 FY2025 | EPS (GAAP) | $0.62 – $0.80 | $0.75 | Within range |
| Q3 FY2025 | non-GAAP net income per diluted share | $0.69 – $0.87 | $0.85 | Within range |
| Q3 FY2025 | Revenue | $710.00M – $770.00M | $769.00M | Within range |
| Q2 FY2025 | EPS (GAAP) | $0.35 – $0.58 | $0.49 | Within range |
| Q2 FY2025 | non-GAAP net income per diluted share | $0.41 – $0.64 | $0.57 | Within range |
| Q2 FY2025 | Revenue | $610.00M – $680.00M | $652.00M | Within range |
| Q1 FY2025 | EPS (GAAP) | $0.48 – $0.59 | $0.61 | Above range |
| Q1 FY2025 | non-GAAP net income per diluted share | $0.58 – $0.68 | $0.75 | Above range |
| Q1 FY2025 | Revenue | $660.00M – $700.00M | $686.00M | Within range |
| Q4 FY2024 | EPS (GAAP) | $0.73 – $0.91 | $0.90 | Within range |
| Q4 FY2024 | non-GAAP net income per diluted share | $0.80 – $0.97 | $0.95 | Within range |
| Q4 FY2024 | Revenue | $710.00M – $760.00M | $753.00M | Within range |
| Q3 FY2024 | EPS (GAAP) | $0.62 – $0.82 | $0.89 | Above range |
| Q3 FY2024 | non-GAAP net income per diluted share | $0.66 – $0.86 | $0.90 | Above range |
| Q3 FY2024 | Revenue | $680.00M – $740.00M | $737.00M | Within range |
| Q2 FY2024 | EPS (GAAP) | $0.90 – $1.10 | $1.14 | Above range |
| Q2 FY2024 | non-GAAP net income per diluted share | $0.64 – $0.84 | $0.86 | Above range |
| Q2 FY2024 | Revenue | $665.00M – $725.00M | $730.00M | Above range |
| Q1 FY2024 | EPS (GAAP) | $0.19 – $0.35 | $0.40 | Above range |
| Q1 FY2024 | non-GAAP net income per diluted share | $0.22 – $0.38 | $0.51 | Above range |
| Q1 FY2024 | Revenue | $540.00M – $590.00M | $600.00M | Above range |
| Q4 FY2023 | EPS (GAAP) | $0.58 – $0.78 | $0.72 | Within range |
| Q4 FY2023 | non-GAAP net income per diluted share | $0.61 – $0.81 | $0.79 | Within range |
| Q4 FY2023 | Revenue | $640.00M – $700.00M | $671.00M | Within range |
| Q3 FY2023 | EPS (GAAP) | $0.57 – $0.77 | $0.78 | Above range |
| Q3 FY2023 | non-GAAP net income per diluted share | $0.61 – $0.81 | $0.80 | Within range |
| Q3 FY2023 | Revenue | $650.00M – $710.00M | $704.00M | Within range |
| Q2 FY2023 | EPS (GAAP) | $0.53 – $0.72 | $0.73 | Above range |
| Q2 FY2023 | non-GAAP net income per diluted share | $0.55 – $0.74 | $0.79 | Above range |
| Q2 FY2023 | Revenue | $625.00M – $685.00M | $684.00M | Within range |
| Q1 FY2022 | EPS (GAAP) | $0.71 – $0.93 | $0.92 | Within range |
| Q1 FY2022 | non-GAAP net income per diluted share | $0.76 – $0.98 | $0.98 | Within range |
| Q1 FY2022 | Revenue | $700.00M – $770.00M | $755.00M | Within range |
| Q4 FY2021 | EPS (GAAP) | $1.08 – $1.33 | $1.29 | Within range |
| Q4 FY2021 | non-GAAP net income per diluted share | $1.14 – $1.40 | $1.37 | Within range |
| Q4 FY2021 | Revenue | $820.00M – $900.00M | $885.00M | Within range |
Guidance history
Every forecast Teradyne put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | non-GAAP net income attributable to Teradyne per diluted share | Q4 FY2026 | $1.95 – $2.25 | New |
| Oct 28, 2026 | GAAP net income attributable to Teradyne per diluted share | Q4 FY2026 | $1.88 – $2.18 | New |
| Oct 28, 2026 | revenue | Q4 FY2026 | $1.25B – $1.35B | New |
| Jul 29, 2026 | non-GAAP net income attributable to Teradyne per diluted share | Q3 FY2026 | $1.85 – $2.15 | New |
| Jul 29, 2026 | GAAP net income attributable to Teradyne per diluted share | Q3 FY2026 | $1.79 – $2.09 | New |
| Jul 29, 2026 | revenue | Q3 FY2026 | $1.20B – $1.30B | New |
| Apr 29, 2026 | non-GAAP net income per diluted share | Q2 FY2026 | $1.86 – $2.15 | New |
| Apr 29, 2026 | GAAP net income per diluted share | Q2 FY2026 | $1.83 – $2.12 | New |
| Apr 29, 2026 | revenue | Q2 FY2026 | $1.15B – $1.25B | New |
| Feb 3, 2026 | non-GAAP net income per diluted share | Q1 FY2026 | $1.89 – $2.25 | New |
| Feb 3, 2026 | GAAP net income per diluted share | Q1 FY2026 | $1.82 – $2.19 | New |
| Feb 3, 2026 | revenue | Q1 FY2026 | $1.15B – $1.25B | New |
| Oct 29, 2025 | non-GAAP net income per diluted share | Q4 FY2025 | $1.20 – $1.46 | New |
| Oct 29, 2025 | GAAP net income per diluted share | Q4 FY2025 | $1.12 – $1.39 | New |
| Oct 29, 2025 | revenue | Q4 FY2025 | $920.00M – $1.00B | New |
| Oct 29, 2025 | sales sequential growth | Q4 FY2025 | +25% | New |
| Oct 29, 2025 | sales year-over-year growth | Q4 FY2025 | +27% | Raised |
| Jul 30, 2025 | non-GAAP net income per diluted share | Q3 FY2025 | $0.69 – $0.87 | New |
| Jul 30, 2025 | GAAP net income per diluted share | Q3 FY2025 | $0.62 – $0.80 | New |
| Jul 30, 2025 | revenue | Q3 FY2025 | $710.00M – $770.00M | New |
| Apr 29, 2025 | non-GAAP net income per diluted share | Q2 FY2025 | $0.41 – $0.64 | New |
| Apr 29, 2025 | GAAP net income per diluted share | Q2 FY2025 | $0.35 – $0.58 | New |
| Apr 29, 2025 | revenue | Q2 FY2025 | $610.00M – $680.00M | New |
| Jan 30, 2025 | non-GAAP net income per diluted share | Q1 FY2025 | $0.58 – $0.68 | New |
| Jan 30, 2025 | GAAP net income per diluted share | Q1 FY2025 | $0.48 – $0.59 | New |
| Jan 30, 2025 | revenue | Q1 FY2025 | $660.00M – $700.00M | New |
| Oct 24, 2024 | non-GAAP net income per diluted share | Q4 FY2024 | $0.80 – $0.97 | New |
| Oct 24, 2024 | GAAP net income per diluted share | Q4 FY2024 | $0.73 – $0.91 | New |
| Oct 24, 2024 | revenue | Q4 FY2024 | $710.00M – $760.00M | New |
| Jul 25, 2024 | non-GAAP net income per diluted share | Q3 FY2024 | $0.66 – $0.86 | New |
| Jul 25, 2024 | GAAP net income per diluted share | Q3 FY2024 | $0.62 – $0.82 | New |
| Jul 25, 2024 | revenue | Q3 FY2024 | $680.00M – $740.00M | New |
| Apr 25, 2024 | non-GAAP net income per diluted share | Q2 FY2024 | $0.64 – $0.84 | New |
| Apr 25, 2024 | GAAP net income per diluted share | Q2 FY2024 | $0.90 – $1.10 | New |
| Apr 25, 2024 | revenue | Q2 FY2024 | $665.00M – $725.00M | New |
| Jan 31, 2024 | non-GAAP net income per diluted share | Q1 FY2024 | $0.22 – $0.38 | New |
| Jan 31, 2024 | GAAP net income per diluted share | Q1 FY2024 | $0.19 – $0.35 | New |
| Jan 31, 2024 | revenue | Q1 FY2024 | $540.00M – $590.00M | New |
| Oct 26, 2023 | non-GAAP net income per diluted share | Q4 FY2023 | $0.61 – $0.81 | New |
| Oct 26, 2023 | GAAP net income per diluted share | Q4 FY2023 | $0.58 – $0.78 | New |
| Oct 26, 2023 | revenue | Q4 FY2023 | $640.00M – $700.00M | New |
| Jul 27, 2023 | non-GAAP net income per diluted share | Q3 FY2023 | $0.61 – $0.81 | New |
| Jul 27, 2023 | GAAP net income per diluted share | Q3 FY2023 | $0.57 – $0.77 | New |
| Jul 27, 2023 | revenue | Q3 FY2023 | $650.00M – $710.00M | New |
| Apr 27, 2023 | non-GAAP net income per diluted share | Q2 FY2023 | $0.55 – $0.74 | New |
| Apr 27, 2023 | GAAP net income per diluted share | Q2 FY2023 | $0.53 – $0.72 | New |
| Apr 27, 2023 | revenue | Q2 FY2023 | $625.00M – $685.00M | New |
| Oct 26, 2022 | non-GAAP net income per diluted share | Q4 FY2022 | $0.62 – $0.86 | New |
| Oct 26, 2022 | GAAP net income per diluted share | Q4 FY2022 | $0.59 – $0.84 | New |
| Oct 26, 2022 | revenue | Q4 FY2022 | $670.00M – $750.00M | New |
| Apr 27, 2022 | non-GAAP net income per diluted share | Q2 FY2022 | $1.00 – $1.29 | New |
| Apr 27, 2022 | GAAP net income per diluted share | Q2 FY2022 | $0.96 – $1.25 | New |
| Apr 27, 2022 | revenue | Q2 FY2022 | $780.00M – $870.00M | New |
| Jan 27, 2022 | non-GAAP net income per diluted share | Q1 FY2022 | $0.76 – $0.98 | New |
| Jan 27, 2022 | GAAP net income per diluted share | Q1 FY2022 | $0.71 – $0.93 | New |
| Jan 27, 2022 | revenue | Q1 FY2022 | $700.00M – $770.00M | New |
| Oct 27, 2021 | non-GAAP net income per diluted share | Q4 FY2021 | $1.14 – $1.40 | New |
| Oct 27, 2021 | GAAP net income per diluted share | Q4 FY2021 | $1.08 – $1.33 | New |
| Oct 27, 2021 | revenue | Q4 FY2021 | $820.00M – $900.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Teradyne filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Update
- Results
- News
- Results
- Results
- Results
- Results
- Results